Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Oct 22, 2026
TickeronGET DAILY SIGNALS
Why Is Auna S.A. (AUNA) Stock Down -14.6% Today?

Why Is Auna S.A. (AUNA) Stock Down -14.6% Today?

Key Takeaways

  • Shares of AUNA tumbled roughly 14.6%, falling to about $4.62 from a prior close of $5.41.
  • The primary catalyst was a sharp cut to the company's full-year 2026 Adjusted EBITDA guidance.
  • Management now expects Adjusted EBITDA to be broadly flat year over year, down from prior guidance of 10% to 14% FX-neutral growth.
  • The revision stems from unexpected advanced-stage cancer cases under a specific Colombia payor contract, creating temporary cost pressure.
  • Full-year revenue guidance was maintained at roughly 12% FX-neutral growth, supported by a recovery in Mexico.
  • Traders are watching the upcoming third-quarter earnings call for more detail on the Colombia contract's impact.

Opening Summary

Auna S.A. (AUNA), a Latin American healthcare platform operating hospitals, clinics, and health plans across Mexico, Peru, and Colombia, saw its stock plunge in Thursday's session after the company slashed its 2026 Adjusted EBITDA outlook. The shares fell approximately 14.6%, dropping to about $4.62 from the previous session's closing price of $5.41. Markets pointed to the guidance downgrade — driven by unexpected cost pressure tied to a Colombian payor contract — as the immediate reason for the sell-off.

Guidance Cut: The Core Catalyst

The decisive driver of the decline was Auna's announcement that it now expects consolidated Adjusted EBITDA to be broadly stable year over year for 2026, a sharp downgrade from its earlier guidance of 10% to 14% growth on an FX-neutral basis. The revision follows an unexpectedly high incidence of advanced-stage cancer cases within a covered population under a specific payor contract in Colombia, which has created additional temporary cost pressure for the company.

The move represents a step down from signals management had already given during its second-quarter earnings call, when it indicated full-year Adjusted EBITDA growth was expected to land at the lower end of guidance excluding one-time effects. The further cut caught investors off guard, triggering a broad repricing of the stock.

Revenue Guidance Held, Mexico Recovery Intact

Despite the profit warning, Auna maintained its full-year 2026 revenue guidance of approximately 12% FX-neutral growth. The company attributed that confidence to a continued strong recovery in its Mexico operations during the second half of the year, with recently disclosed operating KPIs reflecting favorable volume and specialty-service trends in the third quarter.

Capital expenditures also remain within the previously communicated range of roughly 4.0% of consolidated revenue, and the company said free cash flow and leverage continue to evolve favorably. Those stabilizing factors, however, were not enough to offset investor concern over the profitability reset in Colombia.

Market Context and Trading Activity

The stock's decline came on a day when Auna was also hosting its 2026 Investor Day, at which management discussed its long-term strategy across Mexico, Peru, and Colombia. The guidance revision overshadowed the event, and selling pressure was evident from the premarket session onward, with the shares gapping down sharply before settling near the lows.

The move reflected company-specific fundamentals rather than broad sector weakness, as the negative catalyst — a contract-driven cost surprise — was idiosyncratic to Auna's Colombian operations. Management noted it is still completing its review of the payor contract's implications for full-year Adjusted EBITDA, leaving some uncertainty about whether further adjustments could follow.

What Comes Next for AUNA

Investors will now focus on Auna's third-quarter 2026 earnings call, where management has said it will provide additional detail on the Colombia payor contract and its effect on full-year Adjusted EBITDA. The company has indicated that its revenue trajectory remains intact, but the key question is whether the cost pressures prove temporary, as management described, or persist into future quarters.

Beyond the upcoming earnings report, traders will monitor the pace of Mexico's operational recovery, the stability of Auna's free cash flow and leverage metrics, and any further disclosures on the Colombia contract. The reset in guidance introduces meaningful uncertainty around near-term profitability, even as the top-line outlook remains supportive.

Trending AI Robots

For traders seeking a data-driven edge, Tickeron's Trending AI Robots page highlights AI-powered trading bots that are performing well under current market conditions. Tickeron offers hundreds of AI trading bots covering thousands of tickers, but only the strongest performers are featured in this curated section. Bots vary by strategy, timeframe, performance metrics, and traded symbols, giving users a range of approaches to explore. Visit the page to see which strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: AUNA

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


AUNA sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for AUNA moved below the 200-day moving average on November 03, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AUNA as a result. In 41 of 56 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 73%.

The Moving Average Convergence Divergence Histogram (MACD) for AUNA turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 22 similar instances when the indicator turned negative. In 14 of the 22 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

AUNA moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AUNA crossed bearishly below the 50-day moving average on October 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 8 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AUNA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 73%.

The Aroon Indicator for AUNA entered a downward trend on November 20, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +3.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where AUNA advanced for three days, in 75 of 121 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

AUNA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 2 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 64 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.186) is normal, around the industry mean (204.532). P/E Ratio (21.273) is within average values for comparable stocks, (21.572). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.153) among similar stocks. P/S Ratio (0.289) is also within normal values, averaging (2.688).

The Tickeron Price Growth Rating for this company is 77 (best 1 - 100 worst), indicating slightly worse than average price growth. AUNA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 89 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AUNA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

Notable companies

The most notable companies in this group are DaVita (NYSE:DVA), Community Health Systems (NYSE:CYH), WW International Inc (NASDAQ:WW).

Industry description

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

Market Cap

The average market capitalization across the Hospital/Nursing Management Industry is 5.37B. The market cap for tickers in the group ranges from 20.9K to 107.17B. HCA holds the highest valuation in this group at 107.17B. The lowest valued company is NMMCF at 20.9K.

High and low price notable news

The average weekly price growth across all stocks in the Hospital/Nursing Management Industry was -12%. For the same Industry, the average monthly price growth was -12%, and the average quarterly price growth was 0%. CHE experienced the highest price growth at 0%, while NIVF experienced the biggest fall at -88%.

Volume

The average weekly volume growth across all stocks in the Hospital/Nursing Management Industry was 13%. For the same stocks of the Industry, the average monthly volume growth was 102% and the average quarterly volume growth was 58%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 52
P/E Growth Rating: 49
Price Growth Rating: 59
SMR Rating: 66
Profit Risk Rating: 83
Seasonality Score: -4 (-100 ... +100)
1-on-1 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry HospitalNursingManagement

Industry
N/A
Address
No. 6, rue Jean Monnet
Phone
N/A
Employees
15254
Web
https://www.auna.org
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.